US FDA re-tackles device changes needing a new 510(k)
This article was originally published in Clinica
Executive Summary
The controversial issue of what types of changes made to medical devices already on the US market would warrant a new pre-market notification or 510(k) application is to be discussed at a public meeting organized by the US Food and Drug Administration on 13 June.